Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Coronavirus / COVID-19 Pandemic -- Ignore unavailable to you. Want to Upgrade?

To: FJB who wrote (1375)	4/18/2020 10:16:00 PM
From: emertius	2 Recommendations Recommended By abuelita Glenn Petersen Respond to of 22883

As I am sure you are aware from your extensive education in immunology that IgM not IgG is produce during the initial phase of a COVID-19 virus infection. IgG is only produced later. As such virtually all newly infected individuals will probably test negatively when probed using an assay for viral specific IgG. Moreover, do you have any idea of the accurarcy of the particular test used in Mich or the training of laboratory to properly run the assay or even whether the statement that was alleged to be given by a technician (with 2 years of junior college training) was in fact accurate? Yes the Abbott test is probably very reliable and if it measures IgG can detect an individual a week or more post infection if it is run by a laboratory that is properly trained to use it. Other tests currently out there are not reliable and it will take time for laboratories to work out kinks. This is a major challenge critical re-opening our country and we are not there yet.